Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Larson

Showing results (851-860 of 997) with videos related to

Pageof 100
Sort By:
Obesity (Silver Spring, Md.)|July 21, 2006
PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sampleJames B Meigs, Josée Dupuis, Chunyu Liu, et al.
Atherosclerosis|January 13, 2009
Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart StudyRenate Schnabel, Josée Dupuis, Martin G Larson, et al.
Journal of the American Heart Association|June 10, 2023
Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart StudyYi Li, Ayana Gray, Liying Xue, et al.
Circulation|November 14, 2017
Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial FibrillationLu-Chen Weng, Sarah R Preis, Olivia L Hulme, et al.
European Heart Journal|April 19, 2014
Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart StudyNicolas Amabile, Susan Cheng, Jean Marie Renard, et al.
Circulation|January 10, 2016
Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection FractionRajalakshmi Santhanakrishnan, Na Wang, Martin G Larson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia modelsE D Hall, P K Andrus, S L Smith, et al.
Circulation|August 22, 2012
Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart StudyThomas J Wang, Kai C Wollert, Martin G Larson, et al.
Journal of Medical Internet Research|June 13, 2024
Association of Smartwatch-Based Heart Rate and Physical Activity With Cardiorespiratory Fitness Measures in the Community: Cohort StudyYuankai Zhang, Xuzhi Wang, Chathurangi H Pathiravasan, et al.
Circulation|August 19, 2007
Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring StudyErik Ingelsson, Michael J Pencina, Geoffrey H Tofler, et al.
Pageof 100

Showing results (851-860 of 997) with videos related to

Sort By:
Pageof 100
Obesity (Silver Spring, Md.)|July 21, 2006
PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sampleJames B Meigs, Josée Dupuis, Chunyu Liu, et al.
Atherosclerosis|January 13, 2009
Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart StudyRenate Schnabel, Josée Dupuis, Martin G Larson, et al.
Journal of the American Heart Association|June 10, 2023
Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart StudyYi Li, Ayana Gray, Liying Xue, et al.
Circulation|November 14, 2017
Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial FibrillationLu-Chen Weng, Sarah R Preis, Olivia L Hulme, et al.
European Heart Journal|April 19, 2014
Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart StudyNicolas Amabile, Susan Cheng, Jean Marie Renard, et al.
Circulation|January 10, 2016
Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection FractionRajalakshmi Santhanakrishnan, Na Wang, Martin G Larson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia modelsE D Hall, P K Andrus, S L Smith, et al.
Circulation|August 22, 2012
Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart StudyThomas J Wang, Kai C Wollert, Martin G Larson, et al.
Journal of Medical Internet Research|June 13, 2024
Association of Smartwatch-Based Heart Rate and Physical Activity With Cardiorespiratory Fitness Measures in the Community: Cohort StudyYuankai Zhang, Xuzhi Wang, Chathurangi H Pathiravasan, et al.
Circulation|August 19, 2007
Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring StudyErik Ingelsson, Michael J Pencina, Geoffrey H Tofler, et al.
Pageof 100